- Report
- May 2025
- 196 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- February 2025
- 200 Pages
Global
From €4019EUR$4,490USD£3,424GBP
- Report
- February 2025
- 185 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- May 2025
- 300 Pages
Global
From €3576EUR$3,995USD£3,046GBP
- Report
- May 2025
- 184 Pages
Global
From €3174EUR$3,545USD£2,703GBP
€3526EUR$3,939USD£3,004GBP
- Report
- August 2024
- 142 Pages
Global
From €2685EUR$2,999USD£2,287GBP
- Report
- November 2024
- 171 Pages
Global
From €5326EUR$5,950USD£4,537GBP
- Report
- February 2025
- 200 Pages
Global
From €4019EUR$4,490USD£3,424GBP
- Report
- June 2025
- 127 Pages
Global
From €5237EUR$5,850USD£4,461GBP
- Report
- April 2022
- 290 Pages
Global
From €3737EUR$4,175USD£3,183GBP
- Report
- April 2020
- 63 Pages
Global
- Report
- February 2024
- 117 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- April 2023
- 115 Pages
Global
From €4252EUR$4,750USD£3,622GBP

The Diagnostic Antibodies market is a subset of the Diagnostics industry, which focuses on the development and production of antibodies used to detect and diagnose diseases. Diagnostic antibodies are used to detect the presence of a specific antigen in a sample, such as a blood or tissue sample. These antibodies are used to diagnose a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Diagnostic antibodies are also used to monitor the progression of a disease or to measure the effectiveness of a treatment.
The Diagnostic Antibodies market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abcam, Bio-Rad, Merck, Thermo Fisher Scientific, and Roche. Show Less Read more